Xiaoying Sun

Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease

Rachelle S. Doody, Ronald G. Thomas, Martin R. Farlow et al. · New England Journal of Medicine · 2014 · 1.6K citations · Full text

Medicine, Neurology, Neuroscience +14

A Phase 3 Trial of Semagacestat for Treatment of Alzheimer's Disease

Rachelle S. Doody, Rema Raman, Martin R. Farlow et al. · New England Journal of Medicine · 2013 · 1.2K citations

Medicine, Pharmacology, Pharmacotherapy +17

Infliximab for intensification of primary therapy for Kawasaki disease: a phase 3 randomised, double-blind, placebo-controlled trial

Adriana H. Tremoulet, Sonia Jain, Preeti Jaggi et al. · The Lancet · 2014 · 307 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +9

Risk of Posttraumatic Stress Disorder and Major Depression in Civilian Patients After Mild Traumatic Brain Injury

Murray B. Stein, Sonia Jain, Joseph T. Giacino et al. · JAMA Psychiatry · 2019 · 300 citations · Full text

Medicine, Emergency Medicine, Psychiatry +15

Rutin prevents tau pathology and neuroinflammation in a mouse model of Alzheimer’s disease

Xiaoying Sun, Lingjie Li, Quan-xiu Dong et al. · Journal of Neuroinflammation · 2021 · 265 citations · Full text

Life Sciences, Neurology, Neuroscience +17